Royal Fund Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,698
Closed -$879K 202
2022
Q1
$879K Buy
3,698
+304
+9% +$71.4K 0.13% 120
2021
Q4
$775K Buy
3,394
+30
+0.9% +$6.6K 0.11% 126
2021
Q3
$650K Buy
3,364
+127
+4% +$25.7K 0.09% 127
2021
Q2
$688K Buy
3,237
+56
+2% +$11.8K 0.11% 125
2021
Q1
$649K Buy
+3,181
New +$627K 0.12% 130
2018
Q1
Sell
-13
Closed -$1K 558
2017
Q4
$1K Buy
+13
New +$1.85K ﹤0.01% 616

Other funds holding CME

Royal Fund Management's CME Position: Q2 2022 in Review

Royal Fund Management sold out of CME Group (CME) in Q2 2022, closing a stake of 3,698 shares — an estimated $879K sold.

Royal Fund Management first reported a position in CME in Q4 2017 and held it in 6 quarters. The position peaked at $879K in Q1 2022. 1,158 funds tracked by Wall St. Rank hold CME as of Q2 2022.

  • Royal Fund Management reported no remaining CME Group position as of Q2 2022 after selling out during the quarter.
  • Royal Fund Management sold 3,698 CME Group shares in Q2 2022, an estimated $879K.
  • Royal Fund Management first reported a position in CME Group in Q4 2017 and held it in 6 quarters.
  • Royal Fund Management's CME Group position peaked at $879K in Q1 2022.
  • 1,158 funds tracked by Wall St. Rank held CME Group as of Q2 2022.

Based on Royal Fund Management's 13F filing for Q2 2022, filed 28 Jul 2022.